←Back to Expert Scholars
Translational Medicine / 转化医学Immunotoxicology, Clinical irAE Management
Igor Puzanov
MD, MSCI
🏢Roswell Park Comprehensive Cancer Center🌐USA
Chief of Melanoma
68
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Igor Puzanov has been a leader in developing ASCO/SITC/NCCN guidelines for management of immune-related adverse events. He directs melanoma and early-phase clinical trials at Roswell Park.
Share:
🧪Research Fields 研究领域
melanoma immunotherapy
irAE clinical management
cardiotoxicity checkpoint inhibitors
ESMO/SITC guidelines
early phase trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Igor Puzanov 的研究动态
Follow Igor Puzanov's research updates
留下邮箱，当我们发布与 Igor Puzanov（Roswell Park Comprehensive Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment